Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/1998

01-01-1998

Low cathepsin D and low plasminogen activator type 1 inhibitor in tumor cytosols defines a group of node negative breast cancer patients with low risk of recurrence

Authors: Timothy Edward Kute, Jan Grøndahl-Hansen, Si-Ming Shao, Rena Long, Greg Russell, Nils Brünner

Published in: Breast Cancer Research and Treatment | Issue 1/1998

Login to get access
Metadata
Title
Low cathepsin D and low plasminogen activator type 1 inhibitor in tumor cytosols defines a group of node negative breast cancer patients with low risk of recurrence
Authors
Timothy Edward Kute
Jan Grøndahl-Hansen
Si-Ming Shao
Rena Long
Greg Russell
Nils Brünner
Publication date
01-01-1998
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/1998
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1005882520982

Other articles of this Issue 1/1998

Breast Cancer Research and Treatment 1/1998 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine